10-Year Outcomes in Localized Prostate Cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Protocol for the PROSECCA study: a new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare data.BMJ open · 2026
   Article
2. New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer.Molecular therapy oncolytics · 2023
   Review
3. Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention Trials.Cancers · 2023
   Article
4. Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome.Cancers · 2022
   Review
5. Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?Critical reviews in immunology · 2021
   Review
6. Green tea extract for prevention of prostate cancer progression in patients on active surveillance.Oncotarget · 2018
   Review
7. [Geriatric urology : Increasingly important in urological care].Der Urologe. Ausg. A · 2017
   Review
8. Contemporary Strategies for Clinical Chemoprevention of Localized Prostate Cancer.Cancer control : journal of the Moffitt Cancer Center
   Review
9. Role of chemotherapy in prostate cancer.Asian journal of andrology
   Review

Corrections and comments

• Comment on
  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.2016
• Comment on
  10-Year Outcomes in Localized Prostate Cancer.2017
• Comment on
  10-Year Outcomes in Localized Prostate Cancer.2017
• Comment on
  10-Year Outcomes in Localized Prostate Cancer.2017
• Comment on
  10-Year Outcomes in Localized Prostate Cancer.2017

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as